The language of chromatin modification in human cancers

S Zhao, CD Allis, GG Wang - Nature Reviews Cancer, 2021 - nature.com
The genetic information of human cells is stored in the context of chromatin, which is
subjected to DNA methylation and various histone modifications. Such a 'language'of …

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer

Z Zeng, M Fu, Y Hu, Y Wei, X Wei, M Luo - Molecular Cancer, 2023 - Springer
Cancer stem cells (CSCs), initially identified in leukemia in 1994, constitute a distinct subset
of tumor cells characterized by surface markers such as CD133, CD44, and ALDH. Their …

Biology and relevance of human acute myeloid leukemia stem cells

D Thomas, R Majeti - Blood, The Journal of the American …, 2017 - ashpublications.org
Evidence of human acute myeloid leukemia stem cells (AML LSCs) was first reported nearly
2 decades ago through the identification of rare subpopulations of engrafting cells in …

The leukaemia stem cell: similarities, differences and clinical prospects in CML and AML

D Vetrie, GV Helgason, M Copland - Nature Reviews Cancer, 2020 - nature.com
For two decades, leukaemia stem cells (LSCs) in chronic myeloid leukaemia (CML) and
acute myeloid leukaemia (AML) have been advanced paradigms for the cancer stem cell …

2-Oxoglutarate-dependent dioxygenases in cancer

JA Losman, P Koivunen, WG Kaelin Jr - Nature Reviews Cancer, 2020 - nature.com
Oxoglutarate-dependent dioxygenases (2OGDDs) are a superfamily of enzymes that play
diverse roles in many biological processes, including regulation of hypoxia-inducible factor …

Leukemogenic chromatin alterations promote AML leukemia stem cells via a KDM4C-ALKBH5-AXL signaling axis

J Wang, Y Li, P Wang, G Han, T Zhang, J Chang, R Yin… - Cell stem cell, 2020 - cell.com
Summary N 6-methyladenosine (m 6 A) is a commonly present modification of mammalian
mRNAs and plays key roles in various cellular processes. m 6 A modifiers catalyze this …

[HTML][HTML] Epigenetics and cancer stem cells: unleashing, hijacking, and restricting cellular plasticity

EN Wainwright, P Scaffidi - Trends in cancer, 2017 - cell.com
Epigenetic mechanisms have emerged as key players in cancer development which affect
cellular states at multiple stages of the disease. During carcinogenesis, alterations in …

The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism

S Chang, S Yim, H Park - Experimental & molecular medicine, 2019 - nature.com
Recent studies on mutations in cancer genomes have distinguished driver mutations from
passenger mutations, which occur as byproducts of cancer development. The cancer …

[HTML][HTML] In colorectal cancer cells with mutant KRAS, SLC25A22-mediated glutaminolysis reduces DNA demethylation to increase WNT signaling, stemness, and drug …

CC Wong, J Xu, X Bian, JL Wu, W Kang, Y Qian, W Li… - Gastroenterology, 2020 - Elsevier
Background & Aims Mutant KRAS promotes glutaminolysis, a process that uses steps from
the tricarboxylic cycle to convert glutamine to α-ketoglutarate and other molecules via …

Escape from treatment; the different faces of leukemic stem cells and therapy resistance in acute myeloid leukemia

N Van Gils, F Denkers, L Smit - Frontiers in oncology, 2021 - frontiersin.org
Standard induction chemotherapy, consisting of an anthracycline and cytarabine, has been
the first-line therapy for many years to treat acute myeloid leukemia (AML). Although this …